Jb Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
1579
-20.4(-1.28%)

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. The company manufactures a range of specialty products that include various pharmaceutical dosage forms. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and medicated and herbal lozenges. The company was incorporated in 1976 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

1588.35

TODAY'S LOW

1560

52 WEEK HIGH

1985

52 WEEK LOW

1370

Major Holders

% of Shares Held by
All Insider

54.36%

% of Shares Held by
Institutions

22.95%

% of Float Held by
Institutions

50.28%

Number of Institutions
Holding Shares

68

Company Overview

MARKET CAP

12211.90 Cr.

ETERPRISE VALUE

11764.05 Cr.

NO. OF SHARES

7.72 Cr.

BOOK VALUE

256.163

DIV. YIELD

8.5%

DEBT

55.46 Cr.

GROSS PROFIT

1319.80 Cr.

CASH

767.30 Cr.

REVENUE

2328.11 Cr.

REVENUE/SHARE

301.256

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-224.06 Cr.91.25 Cr.10.37 Cr.6 Cr.
Change To Liabilities46.47 Cr.52.10 Cr.-28.57 Cr.19.36 Cr.
Total cashflows from Investing Activities-230.67 Cr.23.92 Cr.-27.66 Cr.-20.68 Cr.
Net Borrowings-7.83 Cr.-2.36 Cr.-5 Lakhs3.95 Cr.
Total Cash from Financing Activities-87.42 Cr.-306.05 Cr.-155.73 Cr.-59.52 Cr.
Other Liabilities0021 Cr.21 Cr.
Total Assets0000
Net Income447.96 Cr.272.04 Cr.193.46 Cr.138.34 Cr.
Change in Cash-3.27 Cr.-6.38 Cr.10.89 Cr.42.71 Cr.
Effect of Exchange Rate3.55 Lakhs-1.29 Lakhs-2.31 Lakhs-2.31 Lakhs
Total Cash from Operating Activities314.78 Cr.275.74 Cr.194.32 Cr.122.92 Cr.
Depreciation68.32 Cr.65.99 Cr.54.87 Cr.56.05 Cr.
Other Cashflows from Investing Activities1.27 Cr.3.17 Cr.3.75 Cr.1.88 Cr.
Dividends Paid-73.24 Cr.-141 Cr.-20.79 Cr.-10.33 Cr.
Change to Inventory-70.08 Cr.-30.91 Cr.-30.02 Cr.-13.56 Cr.
Change to Account Receivables-70.59 Cr.-11.49 Cr.-13.87 Cr.-52.87 Cr.
Other Cashflows from Financing Activities-6.34 Cr.-1.86 Cr.-3.86 Cr.-3.13 Cr.
Change to Net Income-107.63 Cr.-72.32 Cr.-3.31 Cr.-25.31 Cr.
Capital Expenditures-47.77 Cr.-72.96 Cr.-49.12 Cr.-36.42 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax596.88 Cr.348.89 Cr.286.99 Cr.193.95 Cr.
Minority Interest3.70 Cr.2.50 Cr.2.80 Cr.2.77 Cr.
Net Income487.31 Cr.318.21 Cr.258.25 Cr.164.97 Cr.
Selling General Administrative425.77 Cr.406.83 Cr.382.03 Cr.321.24 Cr.
Gross Profit1319.80 Cr.1122.22 Cr.1023.93 Cr.856.08 Cr.
Ebit487.31 Cr.318.21 Cr.258.25 Cr.164.97 Cr.
Operating Income487.31 Cr.318.21 Cr.258.25 Cr.164.97 Cr.
Other Operating Expenses338.05 Cr.330.84 Cr.328.13 Cr.313.03 Cr.
Interest Expense-6.74 Cr.-2.91 Cr.-3.41 Cr.-2.32 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense148.36 Cr.76.50 Cr.93.02 Cr.55.23 Cr.
Total Revenue2042.52 Cr.1774.72 Cr.1643.20 Cr.1408.38 Cr.
Total Operating Expenses1555.21 Cr.1456.51 Cr.1384.94 Cr.1243.40 Cr.
Cost of Revenue722.71 Cr.652.50 Cr.619.26 Cr.552.30 Cr.
Total Other Income Expense Net109.57 Cr.30.67 Cr.28.73 Cr.28.97 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.448.52 Cr.272.39 Cr.193.96 Cr.138.71 Cr.
Net Income Applicable to Common Shares447.96 Cr.272.04 Cr.193.46 Cr.138.34 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets32.10 Cr.30.09 Cr.23.37 Cr.22.65 Cr.
Capital Surplus50.76 Cr.50.76 Cr.50.76 Cr.50.76 Cr.
Total Liabilities424.68 Cr.382.57 Cr.309.02 Cr.320.77 Cr.
Stock Holder Equity1809.72 Cr.1435.48 Cr.1480.12 Cr.1441.55 Cr.
Minority Interest3.70 Cr.2.50 Cr.2.80 Cr.2.77 Cr.
Other Liabilities102.68 Cr.103.72 Cr.97.03 Cr.119.90 Cr.
Total Assets2238.11 Cr.1820.56 Cr.1791.94 Cr.1765.10 Cr.
Common Stock15.45 Cr.15.45 Cr.16.04 Cr.16.71 Cr.
Retained Earnings1735.41 Cr.1373.37 Cr.1413.87 Cr.1371.58 Cr.
Other Liabilities74.27 Cr.68.07 Cr.64.83 Cr.45.65 Cr.
Good Will57.45 Cr.53.14 Cr.53.14 Cr.53.14 Cr.
Treasury Stock8.08 Cr.-4.10 Cr.-56.98 Lakhs2.48 Cr.
Other Assets13.38 Cr.10.52 Cr.8.89 Cr.11.02 Cr.
Cash28.68 Cr.29 Cr.35.39 Cr.27.94 Cr.
Current Liabilities345.27 Cr.313.26 Cr.244.18 Cr.275.11 Cr.
Long Term Asset Charges6.94 Cr.6.57 Cr.00
Short Long Term Debt0000
Other Stockholder Equity8.08 Cr.-4.10 Cr.-56.98 Lakhs2.48 Cr.
Property Plant Equipment569.65 Cr.584.19 Cr.559.50 Cr.581.11 Cr.
Total Cur. Assets1552.60 Cr.1073.15 Cr.1051.15 Cr.1047.21 Cr.
Long Term Investments12.90 Cr.69.45 Cr.95.87 Cr.49.95 Cr.
Net Tangible Assets1720.16 Cr.1352.25 Cr.1403.60 Cr.1365.76 Cr.
Short Term Investments002.99 Cr.84.43 Lakhs
Net Receivables399.24 Cr.361.35 Cr.324.83 Cr.307.32 Cr.
Long Term Debt0000
Inventory347.44 Cr.274.66 Cr.243.75 Cr.213.73 Cr.
Accounts Payable186.92 Cr.167.96 Cr.117.37 Cr.110.39 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account